Ames National Corp’s Whitehawk Therapeutics WHWK Stock Holding History

Ames National Corp’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,571	Closed	-$1.33M	–	70
2026 Q1	$1.33M	Buy	+4,571	New	+$14.3K	0.8%	24

Other funds holding WHWK

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KVP Capital Advisors San Francisco, California $136M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ames National Corp's WHWK Position: Q2 2026 in Review

Ames National Corp sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 4,571 shares — an estimated $1.33M sold.

Ames National Corp first reported a position in WHWK in Q1 2026 and held it in 1 quarter. The position peaked at $1.33M in Q1 2026. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

Ames National Corp reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
Ames National Corp sold 4,571 Whitehawk Therapeutics shares in Q2 2026, an estimated $1.33M.
Ames National Corp first reported a position in Whitehawk Therapeutics in Q1 2026 and held it in 1 quarter.
Ames National Corp's Whitehawk Therapeutics position peaked at $1.33M in Q1 2026.
77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Ames National Corp's 13F filing for Q2 2026, filed 13 Aug 2026.